Table 2.
Summary of FCV prevalence observed in each of the five colonies
| Colony ID | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| A |
B |
C |
D |
E |
|||||
| Time (months) | FCV prevalence | Time (months) | FCV prevalence | Time (months) | FCV prevalence | Time (months) | FCV prevalence | Time (months) | FCV prevalence |
| 0 | 11/16 (69%) | 0 | 4/6 (67%) | 0 | 0/5 (0%) | 0 | 10/20 (50%) | 0 | 2/18 (11%) |
| 4 | 5/15 (33%) | 1a | 4/5 (80%) | 3 | 1/4 (25%) | 1 | 15/23 (65%) | 3 | 1/14 (7%) |
| 19 | 4/20 (20%) | 4 | 6/11 (55%) | 6 | 2/5 (40%) | 6 | 12/28 (43%) | 5 | 0/11 (0%) |
| 23 | 11/21 (52%) | 9 | 9/11 (82%) | 10 | 0/10 (0%) | 14 | 12/21 (57%) | 5 | 0/21 (0%) |
| 28 | 4/17 (24%) | 15 | 10/11 (91%) | 13 | 1/19 (5%) | 20 | 17/27 (63%) | 8 | 1/24 (4%) |
| 30b | 6/10 (60%) | 17 | 0/7 (0%) | 25 | 13/25 (52%) | 12 | 0/18 (0%) | ||
| 30 | 3/9 (33%) | 24 | 0/12 (0%) | 33 | 13/27 (48%) | 15 | 2/25 (8%) | ||
| 31 | 12/27 (44%) | 39 | 3/21 (14%) | 21 | 3/29 (10%) | ||||
| 37 | 9/22 (41%) | 46 | 3/25 (12%) | ||||||
| Overall FCV prevalence | 65/157 (41%) | 33/44 (75%) | 4/62 (6%) | 98/217 (45%) | 9/160 (6%) | ||||
FCV prevalence was calculated as the number of cats positive for FCV/the number of cats sampled on that specific occasion (%).
FeHV-1 also isolated at this time point at a prevalence of 1/5 (20%).
FeHV-1 also isolated at this time point at a prevalence of 5/10 (50%).